Sep. 1, 2013

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of the Safety and Analgesic Efficacy of MNK-795 Controlled-Release Oxycodone/Acetaminophen Tablets (CR OC/APAP) in an Acute Pain Model.

 

Controlled-release OC/APAP is being developed to manage moderate to severe acute pain that warrants manage moderate to severe acute pain that warrants treatment with an opioid analgesic
Designed to provide both fast onset of analgesia ( Tablets employ a dual-layer biphasic delivery mechanism that, when administered as a single dose ( , when administered as a single dose (ie, 2 tablets , 2 tablets)
ensures:

Download PDF